Wednesday, February 10, 2010, 3:52pm SGT - The Singapore stock market closes in 1 hour and 8 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Aethlon Medical Inc. (AEMD.OB)

At 4:50AM SGT: 0.34 USD   0.00 (0.00%)  
 MORE ON AEMD.OB 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 AETHLON MEDICAL INC (OTC BB:AEMD.OB) Delayed quote dataEdit
Last Trade:0.34 USD
Trade Time:4:50AM SGT
Change: 0.00 (0.00%)
Prev Close:0.34
Open:0.32
Bid:0.32 x 5000
Ask:0.34 x 5000
1y Target Est:1.00
Day's Range:0.32 - 0.34
52wk Range:0.12 - 0.73
Volume:21,535
Avg Vol (3m):161,678
Market Cap:19.90M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AEMD.OB to Portfolio   Download Data

 HEADLINES 
•Aethlon Medical Discloses Hepatitis-C (HCV) Treatment Publication
PR Newswire (Tue, Jan 26)
•Aethlon Medical to Present at 12th International Conference on Dialysis
PR Newswire (Wed, Jan 20)
•RedChip Visibility Issues Research Update on Aethlon Medical
GlobeNewswire (Thu, Jan 14)
•Aethlon Medical Releases Shareholder Update
PR Newswire (Thu, Jan 7)
•RedChip Small-Cap Radio Show Expands to Major Markets
GlobeNewswire (Tue, Jan 5)
•Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board
PR Newswire (Tue, Dec 15)
•Aethlon Medical Releases Shareholder Letter
PR Newswire (Tue, Dec 8)
•Aethlon Medical to Present at LD MICRO Conference on December 3, 2009
PR Newswire (Tue, Dec 1)
•AETHLON MEDICAL INC Financials
EDGAR Online Financials (Sun, Nov 22)
•RedChip Companies Announces Its 2009 Top-Performing Stocks
GlobeNewswire (Mon, Oct 26)
More Headlines for AEMD.OB...
 ANALYST 
EPS Est (next year) (Mar-10) :N/A
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Aethlon Medical, Inc., a development stage medical device company, focuses on research and development of diagnostic and therapeutic filtration devices to improve the health of individuals afflicted with infectious diseases and cancer.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices